Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of NCOR1 mRNA | decreases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NCOR1 mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen promotes the reaction [NCOR1 protein binds to TFF1 promoter] | affects binding|increases reaction | 19858209
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NCOR1 mRNA | affects expression | 17562736
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter] | affects binding|decreases reaction | 16648561
|
D013196 |
Dihydrotestosterone |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]] | affects binding|decreases reaction | 16648561
|
D013196 |
Dihydrotestosterone |
NCOR1 protein inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein] | affects binding|decreases reaction|increases activity | 17804755
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NCOR1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NCOR1 mRNA | decreases expression | 19150397
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased stability of and results in increased expression of NCOR1 protein | increases expression|increases stability | 15857753
|
C006780 |
bisphenol A |
bisphenol A affects the expression of NCOR1 mRNA | affects expression | 19696011
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of NCOR1 mRNA | affects expression | 12734012
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of NCOR1 mRNA | decreases expression | 16644059
|
D017373 |
Cyproterone Acetate |
[Cyproterone Acetate binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter] | affects binding|increases reaction | 15308689
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [NCOR1 protein binds to IGF1 promoter] | affects binding|decreases reaction | 17872375
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [NCOR1 protein binds to PTGS2 promoter] | affects binding|decreases reaction | 17872375
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOR1 protein binds to CDKN1A promoter] | affects binding|increases reaction | 20696891
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOR1 protein binds to TFF1 promoter] | affects binding|increases reaction | 19858209 19698761
|
D004958 |
Estradiol |
[Estradiol co-treated with ormeloxifene] promotes the reaction [NCOR1 protein binds to ESR1 protein] | affects binding|affects cotreatment|increases reaction | 19460436
|
D005472 |
Fluorouracil |
NCOR1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] | affects cotreatment|affects response to substance | 18927307
|
C070081 |
fulvestrant |
fulvestrant promotes the reaction [NCOR1 protein binds to TFF2 promoter] | affects binding|increases reaction | 20696891
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NCOR1 mRNA | affects cotreatment|increases expression | 17183730
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of NCOR1 mRNA | decreases expression | 18927307
|
C051890 |
irinotecan |
NCOR1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] | affects cotreatment|affects response to substance | 18927307
|
C008493 |
methylselenic acid |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]] | affects binding|decreases reaction | 16648561
|
D015735 |
Mifepristone |
[Mifepristone binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter] | affects binding|increases reaction | 15308689
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of NCOR1 mRNA | affects expression | 15651846
|
D019319 |
Okadaic Acid |
Okadaic Acid results in decreased activity of NCOR1 protein | decreases activity | 17312396
|
D019319 |
Okadaic Acid |
[Tretinoin co-treated with Okadaic Acid] results in decreased activity of NCOR1 protein | affects cotreatment|decreases activity | 17312396
|
C508548 |
ormeloxifene |
[Estradiol co-treated with ormeloxifene] promotes the reaction [NCOR1 protein binds to ESR1 protein] | affects binding|affects cotreatment|increases reaction | 19460436
|
C508548 |
ormeloxifene |
ormeloxifene promotes the reaction [NCOR1 protein binds to ESR1 protein] | affects binding|increases reaction | 19460436
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] affects the localization of NCOR1 protein | affects cotreatment|affects localization | 17715259
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] results in decreased expression of NCOR1 protein | affects cotreatment|decreases expression | 17715259
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of NCOR1 mRNA | decreases expression | 17616710
|
C119222 |
phorbol-12-myristate |
phorbol-12-myristate promotes the reaction [NR1I2 protein binds to NCOR1 protein] | affects binding|increases reaction | 15710363
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] affects the localization of NCOR1 protein | affects cotreatment|affects localization | 17715259
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] results in decreased expression of NCOR1 protein | affects cotreatment|decreases expression | 17715259
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NCOR1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C013649 |
plastochromanol 8 |
plastochromanol 8 inhibits the reaction [NR1I2 protein binds to NCOR1 protein] | affects binding|decreases reaction | 15269186
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of NCOR1 mRNA | increases expression | 16322246
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOR1 protein binds to TFF1 promoter] | affects binding|increases reaction | 19858209
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOR1 protein binds to TFF2 promoter] | affects binding|increases reaction | 20696891
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NCOR1 mRNA | increases expression | 19465110
|
C082032 |
tocotrienol, alpha |
tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein] | affects binding|decreases reaction | 15269186
|
C082089 |
tocotrienol, beta |
tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] | affects binding|decreases reaction | 15269186
|
C082097 |
tocotrienol, delta |
tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] | affects binding|decreases reaction | 15269186
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Okadaic Acid] results in decreased activity of NCOR1 protein | affects cotreatment|decreases activity | 17312396
|
D014212 |
Tretinoin |
Tretinoin results in decreased activity of NCOR1 protein | decreases activity | 17312396
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NCOR1 mRNA | affects cotreatment|increases expression | 17183730
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NCOR1 mRNA | affects expression | 19015723
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of NCOR1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.16 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.05 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.05 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.59 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.18 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.09 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.09 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.63 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.63 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.51 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.32 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.84 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.59 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.59 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.46 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
7.86 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
7.86 | 19015723 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.84 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.17 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.55 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.55 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.49 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18316065 18940202 17507914 18177632 20603192 18985861 15238991 17157402 17688650 18775368 18396377 16609825 19460635 19232924 18558336 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.04 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.88 | 17594078 20046352 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.78 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.30 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.30 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.30 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.20 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.20 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.52 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 19781322 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.49 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.49 | 16675129 17289903 17261762 17018787 14630087 12948864 18497071 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.49 | 16557594 19217205 16595493 18357371 18608205 16110121 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
3.49 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.49 | 18855134 16873071 19189210 21152245 18629630 20390343 19142967 17049068 19059307 18425577 11161223 19066611 16202921 18821012 20135344 20005174 19084267 17440819 19155303 19103187 17893378 19288272 18815881 16818667 17242785 19200415 19221464 19244106 15565566 20065188 18351453 15668708 20544844 17261762 19189212 18997820 19115204 18984771 16273361 21138602 19289846 19487384 20859285 19410462 19011961 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.49 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.49 | 16873071 16443354 16166294 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.78 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.59 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.21 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.08 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
8.70 | 3786805 15700767 16050911 18705752 16011737 15721981 10355542 16227642 16124888 15673190 16192424 16097048 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
8.70 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.28 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.19 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.13 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.77 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
15.66 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.66 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
15.66 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
15.66 | 17971768 16332177 17045692 16799960 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.66 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.66 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.61 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.83 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
6.85 | 16280240 16757204 18986760 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.85 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
6.85 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.29 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.47 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.47 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.67 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.67 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.67 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.21 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.56 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.55 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.77 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.20 | 15668235 15340226 16354765 8697196 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.20 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.33 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.51 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.70 | 17172411 16510598 17287894 15001691 17016597 17725105 17169374 18772588 16340194 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
3.70 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.63 | 17255274 18802399 17094418 20501625 18949393 16331619 18448328 16303861 14970324 16282729 16391804 18383874 15289873 17401013 15148649 17695437 18288408 16524972 17016601 17454858 17594712 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.63 | 15273666 17159606 18509181 18259882 16303861 16391804 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.99 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.99 | 9142499 17551590 9664655 10589399 8800419 9125849 14991402 16925845 9224671 9211117 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.99 | 8888407 17688650 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
4.99 | 19769572 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.98 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.64 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.41 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.99 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.57 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.78 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.78 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
10.66 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
10.66 | 10774834 11834606 14550746 16109766 19420014 2444490 18713872 15619225 11743745 16081117 16485898 10915739 12540782 11421492 11529661 17522070 11461765 11287661 12153990 19739265 19370779 18071297 11739529 19085960 17562736 15968718 10663392 12958197 12392966 14986274 16781746 12705907 16393943 17906064 19164858 16177239 12594235 19923254 19416960 16227642 14725611 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
10.66 | 16177239 15027814 2869522 3732212 16227642 15968718 10915739 19336974 21278145 3786805 10092053 7120509 6884620 17522070 7440962 11566570 19085960 6623471 9327722 15998439 4309450 7179309 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.66 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
10.66 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.71 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.70 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.32 | 9068938 |
MESH:D004487 |
Edema |
|
Mustard Gas |
9.48 | 11428647 11402378 9260866 11428631 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.48 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.65 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.65 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.18 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
15.75 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
15.75 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
15.75 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
15.75 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
8.06 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.06 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.78 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.53 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.74 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.27 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.92 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.68 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.78 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.15 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.15 | 16785472 16337965 16481741 17638652 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.90 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.90 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
15.99 | 12795759 15959796 61145 19224547 12631006 16239168 17595544 16045604 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.99 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.99 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
15.99 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.00 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.77 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.15 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.80 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.61 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.61 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.61 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.29 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.55 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.91 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.30 | 16452187 |
MESH:D005909 |
Glioblastoma |
marker/mechanism |
|
| 17312396 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
6.88 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.88 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.71 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.93 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.93 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.77 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.93 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.93 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
9.93 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.24 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.03 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.03 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.56 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.64 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.84 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
8.76 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
8.76 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.48 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.63 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.63 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.15 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.20 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.76 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.72 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.25 | 16612254 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
9.89 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.89 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
9.89 | 16467254 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
7.13 | 11402378 8975870 11428647 9357497 16001271 17524151 11428620 9260866 11428631 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.13 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.13 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
3.83 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
10.86 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
10.86 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.86 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.40 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.80 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.80 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
12.59 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
12.59 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.59 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
12.59 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
15.25 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.25 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
15.25 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
15.25 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.58 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.36 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.62 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.62 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.90 | 16935935 17107899 17361223 9834237 16140955 16788101 15748426 17339181 16766008 19075265 12679006 17294898 16331271 17712046 19225113 16823087 19029980 19642359 17301526 19035177 16891316 17649720 17506722 17368321 17217047 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.35 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.04 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.88 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.60 | 11408273 11903743 16943688 17157831 21278145 16221502 16239168 17174718 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.06 | 18317297 12632514 16027843 18472332 15931870 14512876 17900296 17869086 16097048 13678700 15052691 17481882 17766677 12958196 15057751 12546737 18205269 12666154 17944888 14620537 18481824 18277467 15123356 17557913 18166357 12898905 10355542 15925388 17565644 18054572 15959796 17761835 16011737 12389079 16116963 12667390 14716833 15876570 17631135 18210741 16192424 16136751 12632512 18156304 18429990 12649538 17721639 18472094 18279442 15673190 15996030 16015684 18420326 16248980 12609069 17823541 12741479 17698563 18705752 18412020 17976157 15730626 18263696 18395914 14724832 17525996 15650968 17805973 15893842 12445421 16638106 18418968 18395095 18251166 12586293 15370692 15362042 17714472 20821823 18376398 18187930 15818738 16033810 12445418 18339082 17708605 17922224 14716496 11481614 17640975 18006644 14748882 15338365 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.06 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.06 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.06 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.06 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.06 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.06 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.54 | 19784758 16610002 12969438 19460945 11587558 19014921 12587719 16611625 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.54 | 16964402 15830285 17285989 15720792 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.79 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.31 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.31 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
15.95 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
15.95 | 16603448 18383874 15113037 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
15.95 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.95 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
15.95 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
4.97 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
4.97 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
10.88 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
10.88 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
10.88 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.87 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
7.84 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
7.84 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
7.84 | 15276417 17306315 19931552 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.84 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.84 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
7.84 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.41 | 15086387 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.38 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.15 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.15 | 19196723 19196722 16827153 14580682 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.35 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.35 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.64 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.64 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.64 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.80 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.20 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.05 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.92 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.34 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.63 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.69 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.65 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.65 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.98 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.28 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.28 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.48 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.41 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.41 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
10.24 | 18239605 16928823 18600527 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.24 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.24 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.24 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.30 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.61 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.35 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
20.46 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
20.46 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
20.46 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
20.46 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.70 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.70 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
10.70 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.28 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.56 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.35 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.18 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.62 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.72 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.10 | 12819281 16049721 |
MESH:D010024 |
Osteoporosis |
|
ormeloxifene |
5.13 | 15261309 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.61 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.23 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
10.23 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.23 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.23 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.58 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.58 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
4.85 | 16500647 16929163 19003803 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
4.85 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.45 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
20.10 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
20.10 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
20.10 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
20.10 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.55 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.42 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.42 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.03 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.03 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.03 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.03 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.03 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.03 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.03 | 15084515 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.55 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.26 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.71 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.15 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.41 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.40 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.78 | 17266442 17894541 17620002 17720292 10334151 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.69 | 15538739 18286688 16160472 18722050 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.70 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.70 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.09 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.09 | 1511512 11738929 14763951 16876388 3137016 15475178 11044598 17978042 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
4.66 | 12880345 16961503 15451306 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
4.66 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
12.09 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.09 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.09 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.09 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.90 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.66 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.57 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.57 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.15 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.23 | 18396642 15786421 18567086 17172411 17522103 17498489 19015929 19084572 16951190 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.23 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.23 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.22 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.60 | 16684133 16045194 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.56 | 15864552 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.74 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.30 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.73 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.73 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.84 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.99 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.14 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.39 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.39 | 17572228 8653321 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.93 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.63 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
13.95 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.95 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
13.95 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.62 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.22 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.04 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.69 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.65 | 16287080 |